UnitedHealth Group Reports 2025 Results with $2.8B Charge, Forecasts 2026 Revenue Decline & Membership Loss
Summary
UnitedHealth Group reported full year 2025 results impacted by a $2.8 billion charge and issued a 2026 outlook forecasting a revenue decline and significant membership contraction in its UnitedHealthcare segment.
Key Events
-
Full Year 2025 Financial Performance
Consolidated revenues grew 12% year-over-year to $447.6 billion. GAAP earnings per share were $13.23, and adjusted earnings per share were $16.35, both lower than 2024, primarily due to significant one-time charges.
-
Substantial Q4 2025 Charge
The company recorded a $2.8 billion pre-tax charge ($1.6 billion net of taxes) in the fourth quarter of 2025. This charge covered final cyberattack costs, net portfolio divestitures, and broader restructuring activities, including real estate rationalization and workforce reductions.
-
2026 Revenue Outlook Declines
UnitedHealth Group projects 2026 revenues to exceed $439.0 billion, representing a 2% year-over-year decline. This reduction is attributed to 'planned right-sizing across the enterprise'.
-
Significant Membership Contraction Expected
UnitedHealthcare anticipates a substantial decrease in people served for 2026, with membership expected to contract by 2.265 million to 2.815 million. This includes significant reductions in Medicare Advantage and Commercial Risk segments.
Analysis
UnitedHealth Group's latest 8-K reveals a challenging 2025, marked by a substantial $2.8 billion pre-tax charge for cyberattack costs, divestitures, and restructuring, which significantly impacted GAAP and adjusted earnings per share. While 2025 revenues grew, the company is projecting a 2% revenue decline for 2026 due to 'planned right-sizing.' More critically, UnitedHealthcare anticipates a significant membership contraction of 2.265 million to 2.815 million people in 2026, particularly in its Medicare Advantage and Commercial Risk segments. This strategic pivot, including a projected revenue decline for Optum Health, indicates a period of operational adjustment and potential headwinds, despite an improved adjusted EPS outlook for 2026. Investors should monitor the execution of these 'right-sizing' initiatives and their impact on long-term growth and market share.
At the time of this filing, UNH was trading at $308.96 on NYSE in the Finance sector, with a market capitalization of approximately $318.5B. The 52-week trading range was $234.60 to $606.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.